- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CTI wins $20 million in financing
PET developer CTI received a $20-million boost this month from venture capital firm First Union Capital Partners (FUCP). The Knoxville, TN, company will use the capital to underwrite its own growth efforts, as well as those of its affiliate, PETNet
PET developer CTI received a $20-million boost this month from venture capital firm First Union Capital Partners (FUCP). The Knoxville, TN, company will use the capital to underwrite its own growth efforts, as well as those of its affiliate, PETNet Pharmaceutical Services of Norcross, GA. With PETNet, CTI plans to focus on developing its lutetium oxyortho-silicate (LSO) detector material, and new PET-compound manufacturing and distribution centers, according to Terry Douglass, president of CTI.
Charlotte, NC-based FUCPs funding feeds the momentum CTI has generated in the past year. In June, the company won interest at the Society of Nuclear Medicine show in Los Angeles when Siemens Medical Systems displayed images collected by a combination CT/PET scanner developed by CTI PET Systems, the PET joint venture between Siemens and CTI (SCAN 6/24/98). Dr. Henry Wagner of Johns Hopkins in Baltimore named a Siemens CT/PET image as Image of the Year in his post-SNM roundup speech. And in July, CTI acquired Advanced Crystal Technology from Nihon Kessho Koogaku, a subsidiary of Mitsui Mining and Smelting, a deal that gives CTI increased access to bismuth germinate (BGO), a key detector component in PET devices (SCAN 8/4/99).
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
